Trapianto di cellule staminali ematopoietiche dopo condizionamento non mieloablativo

Translated title of the contribution: Nonmyeloablative stem cell transplantation

Research output: Contribution to journalArticle

Abstract

In these last years it has become evident that nonmyeloablative stem cell transplantation (NST) is a feasible procedure at least in the first 100 days. Generally NST has less severe adverse effects than conventional allografting. Unfortunately, short observation period cannot permit us to give a definitive reply to the question if this procedure will substitute the conventional myeloablative transplantation. NST is a promising new option for the treatment of hematologic and non-hematologic neoplasia, which role will be better defined in the near future.

Original languageItalian
Pages (from-to)322-326
Number of pages5
JournalRecenti Progressi in Medicina
Volume92
Issue number5
Publication statusPublished - May 2001

Fingerprint

Stem Cell Transplantation
Homologous Transplantation
Transplantation
Observation
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Trapianto di cellule staminali ematopoietiche dopo condizionamento non mieloablativo. / Carella, Angelo Michele.

In: Recenti Progressi in Medicina, Vol. 92, No. 5, 05.2001, p. 322-326.

Research output: Contribution to journalArticle

@article{8fc569c0b6284db4aec81d3f6b516f1a,
title = "Trapianto di cellule staminali ematopoietiche dopo condizionamento non mieloablativo",
abstract = "In these last years it has become evident that nonmyeloablative stem cell transplantation (NST) is a feasible procedure at least in the first 100 days. Generally NST has less severe adverse effects than conventional allografting. Unfortunately, short observation period cannot permit us to give a definitive reply to the question if this procedure will substitute the conventional myeloablative transplantation. NST is a promising new option for the treatment of hematologic and non-hematologic neoplasia, which role will be better defined in the near future.",
keywords = "Allogeneic marrow transplantation, Hematologic and non-hematologic neoplasia, Nonmyeloablative stem cell transplantation",
author = "Carella, {Angelo Michele}",
year = "2001",
month = "5",
language = "Italian",
volume = "92",
pages = "322--326",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "5",

}

TY - JOUR

T1 - Trapianto di cellule staminali ematopoietiche dopo condizionamento non mieloablativo

AU - Carella, Angelo Michele

PY - 2001/5

Y1 - 2001/5

N2 - In these last years it has become evident that nonmyeloablative stem cell transplantation (NST) is a feasible procedure at least in the first 100 days. Generally NST has less severe adverse effects than conventional allografting. Unfortunately, short observation period cannot permit us to give a definitive reply to the question if this procedure will substitute the conventional myeloablative transplantation. NST is a promising new option for the treatment of hematologic and non-hematologic neoplasia, which role will be better defined in the near future.

AB - In these last years it has become evident that nonmyeloablative stem cell transplantation (NST) is a feasible procedure at least in the first 100 days. Generally NST has less severe adverse effects than conventional allografting. Unfortunately, short observation period cannot permit us to give a definitive reply to the question if this procedure will substitute the conventional myeloablative transplantation. NST is a promising new option for the treatment of hematologic and non-hematologic neoplasia, which role will be better defined in the near future.

KW - Allogeneic marrow transplantation

KW - Hematologic and non-hematologic neoplasia

KW - Nonmyeloablative stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=0035347640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035347640&partnerID=8YFLogxK

M3 - Articolo

C2 - 11413889

AN - SCOPUS:0035347640

VL - 92

SP - 322

EP - 326

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 5

ER -